Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anniek Vlijm

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|December 17, 2008
Experimental study on long-term exposure to a biocompatible, hypertonic, pyruvate-buffered dialysis solutionRoos van Westrhenen, Anniek Vlijm, Johan K Hiralall, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|February 26, 2011
Does Alport syndrome affect the basement membrane of peritoneal vessels?Denise E Sampimon, Anniek Vlijm, Dirk G Struijk, et al.
International Urology and Nephrology|April 1, 2010
No need for an "expiry date" in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis: comments from around the worldDenise E Sampimon, Anniek Vlijm, Dirk G Struijk, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 15, 2007
Effluent hydroxyproline in experimental peritoneal dialysisAnniek Vlijm, Dirk R de Waart, Machteld M Zweers, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 12, 2023
[Weight loss as a presenting clinical feature of malignancy]Jasper L A Vleugels, Anniek Vlijm-Kiewiet, Frank G J Kallenberg, et al.
Nephron. Experimental Nephrology|August 7, 2010
Experimental peritoneal sclerosis models should not be based on chlorhexidine gluconate anymoreAnniek Vlijm, Denise E Sampimon, Marijke de Graaff, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 15, 2013
A two-hit approach in the development of an experimental peritoneal sclerosis modelAnniek Vlijm, Denise E Sampimon, Marijke de Graaff, et al.
NDT Plus|May 19, 2015
Imaging in encapsulating peritoneal sclerosisAnniek Vlijm, Joost van Schuppen, Armand B G N Lamers, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 5, 2010
Encapsulating peritoneal sclerosis in a peritoneal dialysis patient using biocompatible fluids only: is Alport syndrome a risk factor?Denise E Sampimon, Anniek Vlijm, Saffire S K S Phoa, et al.
Contributions to Nephrology|June 5, 2009
Biological markers in the peritoneal dialysate effluent: are they usefulRaymond T Krediet, Denise E Sampimon, Anniek Vlijm, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|December 17, 2008
Experimental study on long-term exposure to a biocompatible, hypertonic, pyruvate-buffered dialysis solutionRoos van Westrhenen, Anniek Vlijm, Johan K Hiralall, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|February 26, 2011
Does Alport syndrome affect the basement membrane of peritoneal vessels?Denise E Sampimon, Anniek Vlijm, Dirk G Struijk, et al.
International Urology and Nephrology|April 1, 2010
No need for an "expiry date" in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis: comments from around the worldDenise E Sampimon, Anniek Vlijm, Dirk G Struijk, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 15, 2007
Effluent hydroxyproline in experimental peritoneal dialysisAnniek Vlijm, Dirk R de Waart, Machteld M Zweers, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 12, 2023
[Weight loss as a presenting clinical feature of malignancy]Jasper L A Vleugels, Anniek Vlijm-Kiewiet, Frank G J Kallenberg, et al.
Nephron. Experimental Nephrology|August 7, 2010
Experimental peritoneal sclerosis models should not be based on chlorhexidine gluconate anymoreAnniek Vlijm, Denise E Sampimon, Marijke de Graaff, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 15, 2013
A two-hit approach in the development of an experimental peritoneal sclerosis modelAnniek Vlijm, Denise E Sampimon, Marijke de Graaff, et al.
NDT Plus|May 19, 2015
Imaging in encapsulating peritoneal sclerosisAnniek Vlijm, Joost van Schuppen, Armand B G N Lamers, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 5, 2010
Encapsulating peritoneal sclerosis in a peritoneal dialysis patient using biocompatible fluids only: is Alport syndrome a risk factor?Denise E Sampimon, Anniek Vlijm, Saffire S K S Phoa, et al.
Contributions to Nephrology|June 5, 2009
Biological markers in the peritoneal dialysate effluent: are they usefulRaymond T Krediet, Denise E Sampimon, Anniek Vlijm, et al.
Pageof 2